Literature DB >> 27632344

Novel 99mTc(III)-azide complexes [99mTc(N3)(CDO)(CDOH)2B-R] (CDOH2=cyclohexanedione dioxime) as potential radiotracers for heart imaging.

Min Liu1, Yumin Zheng2, Ugur Avcibasi3, Shuang Liu4.   

Abstract

INTRODUCTION: In this study, novel 99mTc(III)-azide complexes [99mTc(N3)(CDO)(CDOH)2B-R] (99mTc-ISboroxime-N3: R=IS; 99mTc-MPboroxime-N3: R=MP; 99mTc-PAboroxime-N3: R=PA; 99mTc-PYboroxime-N3: R=PY; and 99mTc-Uboroxime-N3: R=5U) were evaluated as heart imaging agents.
METHODS: Complexes [99mTc(N3)(CDO)(CDOH)2B-R] (R=IS, MP, PA, PY and 5U) were prepared by ligand exchange between NaN3 and [99mTcCl(CDO)(CDOH)2B-R]. Biodistribution and imaging studies were carried out in Sprague-Dawley rats. Image quantification was performed to compare their initial heart uptake and myocardial retention.
RESULTS: 99mTc-ISboroxime-N3, 99mTc-PYboroxime-N3 and 99mTc-Uboroxime-N3 were prepared with high RCP (93-98%) while the RCP of 99mTc-MPboroxime-N3 and 99mTc-PAboroxime-N3 was 80-85%. The myocardial retention curves of 99mTc-ISboroxime-N3, 99mTc-PYboroxime-N3 and 99mTc-Uboroxime-N3 were best fitted to the bi-exponential decay function. The half-time of the fast component was 1.6±0.4min for 99mTc-ISboroxime-N3, 0.7±0.1min for 99mTc-PYboroxime-N3 and 0.9±0.4min for 99mTc-Uboroxime-N3. The 2-min heart uptake from biodistribution studies followed the ranking order of 99mTc-ISboroxime-N3 (3.60±0.68%ID/g)>99mTc-PYboroxime-N3 (2.35±0.37%ID/g)≫99mTc-Uboroxime-N3 (1.29±0.06%ID/g). 99mTc-ISboroxime-N3 had the highest 2-min heart uptake among 99mTc radiotracers revaluated in SD rats. High quality SPECT images were obtained with the right and left ventricular walls being clearly delineated. The best image acquisition window was 0-5min for 99mTc-ISboroxime-N3.
CONCLUSION: Both azide coligand and boronate caps had significant impact on the heart uptake and myocardial retention of complexes [99mTc(N3)(CDO)(CDOH)2B-R]. Among the radiotracers evaluated in SD rats, 99mTc-ISboroxime-N3 has the highest initial heart uptake with the heart retention comparable to that of 99mTc-Teboroxime. 99mTc-ISboroxime-N3 is a promising alternative to 99mTc-Teboroxime for SPECT MPI.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (99m)Tc radiotracers; (99m)Tc-Teboroxime derivatives; heart imaging

Mesh:

Substances:

Year:  2016        PMID: 27632344      PMCID: PMC5077665          DOI: 10.1016/j.nucmedbio.2016.05.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  47 in total

1.  A novel ternary ligand system useful for preparation of cationic (99m)Tc-diazenido complexes and (99m)Tc-labeling of small biomolecules.

Authors:  Young-Seung Kim; Zhengjie He; Wen-Yuan Hsieh; Shuang Liu
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

2.  Combining CT and nuclear: a winning hybrid team.

Authors:  Philipp A Kaufmann; Oliver Gaemperli
Journal:  J Nucl Cardiol       Date:  2009-01-06       Impact factor: 5.952

3.  Nuclear myocardial perfusion imaging with a novel cadmium-zinc-telluride detector SPECT/CT device: first validation versus invasive coronary angiography.

Authors:  Michael Fiechter; Jelena R Ghadri; Silke M Kuest; Aju P Pazhenkottil; Mathias Wolfrum; Rene N Nkoulou; Robert Goetti; Oliver Gaemperli; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-15       Impact factor: 9.236

4.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.

Authors:  P A Carvalho; M L Chiu; J F Kronauge; M Kawamura; A G Jones; B L Holman; D Piwnica-Worms
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

5.  Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes.

Authors:  Young-Seung Kim; Zhengjie He; Wen-Yuan Hsieh; Shuang Liu
Journal:  Bioconjug Chem       Date:  2007-03-13       Impact factor: 4.774

6.  Ultrafast assessment of left ventricular dyssynchrony from nuclear myocardial perfusion imaging on a new high-speed gamma camera.

Authors:  Aju P Pazhenkottil; Ronny R Buechel; Bernhard A Herzog; Rene N Nkoulou; Ines Valenta; Ursula Fehlmann; Jelena-Rima Ghadri; Mathias Wolfrum; Lars Husmann; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-17       Impact factor: 9.236

7.  Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.

Authors:  W L Rumsey; K C Rosenspire; A D Nunn
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

Review 8.  Myocardial perfusion imaging with technetium-99m-teboroxime.

Authors:  L L Johnson
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

9.  Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.

Authors:  Cristina Bolzati; Mario Cavazza-Ceccato; Stefania Agostini; Shinji Tokunaga; Dario Casara; Giuliano Bandoli
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

10.  Development of kit formulations for (99m) TcN-MPO: a cationic radiotracer for myocardial perfusion imaging.

Authors:  Yumin Zheng; Shundong Ji; Elena Tomaselli; Shuang Liu
Journal:  J Labelled Comp Radiopharm       Date:  2014-07-28       Impact factor: 1.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.